1. Home
  2. ITRM vs VVPR Comparison

ITRM vs VVPR Comparison

Compare ITRM & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • VVPR
  • Stock Information
  • Founded
  • ITRM 2015
  • VVPR 2014
  • Country
  • ITRM Ireland
  • VVPR United Kingdom
  • Employees
  • ITRM N/A
  • VVPR N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • VVPR Power Generation
  • Sector
  • ITRM Health Care
  • VVPR Utilities
  • Exchange
  • ITRM Nasdaq
  • VVPR Nasdaq
  • Market Cap
  • ITRM 40.0M
  • VVPR 40.2M
  • IPO Year
  • ITRM 2018
  • VVPR 2016
  • Fundamental
  • Price
  • ITRM $0.48
  • VVPR $2.57
  • Analyst Decision
  • ITRM Strong Buy
  • VVPR
  • Analyst Count
  • ITRM 1
  • VVPR 0
  • Target Price
  • ITRM $9.00
  • VVPR N/A
  • AVG Volume (30 Days)
  • ITRM 1.2M
  • VVPR 591.3K
  • Earning Date
  • ITRM 11-14-2025
  • VVPR 01-01-0001
  • Dividend Yield
  • ITRM N/A
  • VVPR N/A
  • EPS Growth
  • ITRM N/A
  • VVPR N/A
  • EPS
  • ITRM N/A
  • VVPR N/A
  • Revenue
  • ITRM $390,000.00
  • VVPR $61,000.00
  • Revenue This Year
  • ITRM N/A
  • VVPR N/A
  • Revenue Next Year
  • ITRM $482.25
  • VVPR N/A
  • P/E Ratio
  • ITRM N/A
  • VVPR N/A
  • Revenue Growth
  • ITRM N/A
  • VVPR 281.25
  • 52 Week Low
  • ITRM $0.36
  • VVPR $0.62
  • 52 Week High
  • ITRM $3.02
  • VVPR $8.88
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 41.91
  • VVPR 39.10
  • Support Level
  • ITRM $0.36
  • VVPR $2.05
  • Resistance Level
  • ITRM $0.49
  • VVPR $3.64
  • Average True Range (ATR)
  • ITRM 0.05
  • VVPR 0.33
  • MACD
  • ITRM -0.00
  • VVPR -0.00
  • Stochastic Oscillator
  • ITRM 43.47
  • VVPR 33.02

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About VVPR VivoPower International PLC

Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.

Share on Social Networks: